BDTX

NASDAQ · Biotechnology

Black Diamond Therapeutics I

Penny Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$2.26

+0.10 (+4.40%)

As of Feb 8, 2:09 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +1,492.9% upside

Low Target $30.62

Average Target $35.92

High Target $44.24

Current Price $2.26

Current
$2.26

Target
$35.92

$30.62 $35.92 avg $44.24

Scenario Analysis

Bear Case

$30.62

1,257.9%

Low target

Base Case

$35.92

+1,492.9%

Avg target

Bull Case

$44.24

+1,861.9%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$45.36

-95.0% from high

52-Week Low

$23.71

+-90.5% from low

Target vs 52W High

$35.92

-20.8% vs high

Next Earnings Report

Mar 4, 2026 · After Market Close

16d

until earnings

EPS Est: $-0.19

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%